The cost of inaction: Why prevention can’t wait
View in browser
Office of Health Economics | OHE

The Bulletin

Your biweekly update on health economics, policy, and impact

From climate to AMR, what is the bigger picture for health systems?

  • Climate action is health action: OHE’s focus on sustainability
  • From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
  • Reflections from the Region: Healthcare transformation in the Middle East

If you’re short on time, we’ll see you in the next Bulletin. Got a few more minutes? Read on for the details.

Charlotte Ashton-Khan

Charlotte Ashton-Khan, Director

The cost of inaction: Why prevention can’t wait 

 

Prevention works. It saves lives, boosts productivity, and reduces demand on overstretched health systems. Yet despite compelling evidence, prevention remains persistently undervalued and underfunded. Why? 

 

One reason is structural. Within health budgets, prevention is often the first to be cut. Its returns are slow to materialise and typically accrue beyond the health sector, across education, employment, and the environment. That makes it a political and economic outlier, hard to prioritise in short-term budget cycles and within siloed systems of accountability. 

 

The Change Initiative Prevention Programme, delivered in partnership with leading global actors, aims to reframe prevention as a smart, cross-sector investment in resilience. We're exploring how financing and incentives can be reshaped to reflect prevention’s true value, and how better evidence can support long-term thinking in policy and planning. 

 

If we are serious about the sustainability of our health systems, economies, and societies, we need to break the cycle of underinvestment. That starts by asking not what prevention costs, but what failing to prevent truly means. 

 

Valuing health properly in climate policy

Climate action is health action: OHE’s focus on sustainability

Climate change affects health in complex and far-reaching ways that are often overlooked in policy decisions. Health economics offers tools to better measure and value these impacts, ensuring health is not sidelined but central to climate strategies. 

What role should health economics play in climate action?

The value gap in AMR diagnostics

From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics

 

Diagnostics are key to fighting antimicrobial resistance but remain undervalued in policy and practice. This limits their use and innovation, despite clear benefits for health systems. How can we better capture their full value?

New framework shows the role of AMR diagnostics

What’s behind the healthcare reform?

Reflections from the Region: Healthcare transformation in the Middle East

 

Health systems in the Middle East are transforming, with HTA playing a role in shaping policy and access. These changes raise new questions about value, evidence, and equitable care. How can HTA best support this evolving landscape?

The HTA factor in healthcare’s future

Ten years to turn it around:
The economic reality of NHS reform

 

Join us at 18:00 BST on 30th September at the Royal College of Physicians.

 

With the new NHS 10-Year Plan published, this year’s OHE Annual Lecture takes a critical look at what it will take to turn ambition into action. Health economist Anita Charlesworth discusses the realities behind the roadmap and whether today’s choices can meet tomorrow’s challenges.

 

Sign up to our waiting list
Office of Health Economics | OHE

Office of Health Economics, 2nd Floor Goldings House, Hay's Galleria, 2 Hay's Lane, Southwark, London SE1 2HB, United Kingdom, +44 (0) 20 7747 8850

Unsubscribe Manage preferences

LinkedIn
BlueSky
X
Website